Functional Characterization of an AMPA receptor: GluR3

AMPA 受体的功能表征:GluR3

基本信息

  • 批准号:
    7894770
  • 负责人:
  • 金额:
    $ 2.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-07-01 至 2010-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Ionotropic glutamate receptors (iGluR's) are ligand gated ion channels that mediate most of the fast excitatory neurotransmission in the central nervous system. Aberrant function of glutamate neurotransmission can lead to neurological disorders. Drugs designed to target glutamate receptors have the potential to treat a number of neurological conditions. Understanding the relationship between the structure, function and dynamics of glutamate receptors is Important for the development of subtype selective pharmacological agents necessary to treat iGluR related disorders. Single channel electrophysiological studies completed on one specific AMPA receptor subtype (GluR3) will provide functional properties of these receptors induced by different agonists and can be used as a model for future studies on other ionotropic glutamate receptors. The first objective of these studies is to characterize the various levels of conductance classes at different ligand concentrations for a full agonist, glutamate, and a group of structurally related partial agonists, the willardiine compounds. The second objective is to model channel behavior and determine kinetic rates that best represent the mode of channel activation. Single channel data will be analyzed with different methods using QuB software that includes a hidden Markov model approach to event detection. The substrate model and kinetic rates will be compared between the full and partial agonists to determine any similarities or differences in channel function. The rat GluR3 gene has been stably transfected into HEK 293 cells and single channel currents will be measured using the cell attached method. Data will be obtained with an EPC7 amplifier and analog low pass filtered with a Bessel filter at a maximum of 10 kHz. By understanding the kinetics of these channels in the context of the structure of the ligand binding domain, new pharmacological agents can be designed to target a specific component of function. PUBLIC HEALTH RELEVANCE: Numerous acute and chronic neurological conditions involve the function of ion permeable glutamate receptors. However, limited knowledge pertaining to the function of these receptors restricts development of new selective pharmacological agents. Understanding various aspects of glutamate receptors, such as structure and function, will lead to better drug design and better treatment for the large population that suffer from neurological conditions.
描述(由申请人提供):离子型谷氨酸受体(iGluR)是配体门控离子通道,介导中枢神经系统中大部分快速兴奋性神经传递。谷氨酸神经传递功能异常可导致神经系统疾病。旨在靶向谷氨酸受体的药物有可能治疗多种神经系统疾病。了解谷氨酸受体的结构、功能和动力学之间的关系对于开发治疗 iGluR 相关疾病所需的亚型选择性药物非常重要。对一种特定 AMPA 受体亚型 (GluR3) 完成的单通道电生理学研究将提供由不同激动剂诱导的这些受体的功能特性,并可用作其他离子型谷氨酸受体未来研究的模型。这些研究的第一个目标是表征完全激动剂谷氨酸和一组结构相关的部分激动剂威拉丁化合物在不同配体浓度下的不同水平的电导类别。第二个目标是对通道行为进行建模并确定最能代表通道激活模式的动力学速率。将使用 QuB 软件以不同的方法分析单通道数据,其中包括用于事件检测的隐马尔可夫模型方法。将比较完全激动剂和部分激动剂之间的底物模型和动力学速率,以确定通道功能的任何相似性或差异。将大鼠GluR3基因稳定转染至HEK 293细胞中,并使用细胞贴壁法测量单通道电流。数据将通过 EPC7 放大器获得,并使用最大 10 kHz 的贝塞尔滤波器进行模拟低通滤波。通过了解配体结合域结构背景下这些通道的动力学,可以设计新的药物制剂来靶向特定的功能成分。公众健康相关性:许多急性和慢性神经系统疾病都与离子渗透性谷氨酸受体的功能有关。然而,有关这些受体功能的知识有限限制了新的选择性药物的开发。了解谷氨酸受体的各个方面,例如结构和功能,将有助于更好地设计药物,并为大量患有神经系统疾病的人群提供更好的治疗。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KINNING POON其他文献

KINNING POON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KINNING POON', 18)}}的其他基金

Resolving the effects of dietary fat induced maternal CXCL12 on offspring hypothalamus using spatial gene transcriptomics
利用空间基因转录组学解析膳食脂肪诱导的母体 CXCL12 对后代下丘脑的影响
  • 批准号:
    10686263
  • 财政年份:
    2022
  • 资助金额:
    $ 2.1万
  • 项目类别:
Resolving the effects of dietary fat induced maternal CXCL12 on offspring hypothalamus using spatial gene transcriptomics
利用空间基因转录组学解析膳食脂肪诱导的母体 CXCL12 对后代下丘脑的影响
  • 批准号:
    10509951
  • 财政年份:
    2022
  • 资助金额:
    $ 2.1万
  • 项目类别:
CXCL12 promotes development of hypothalamic peptide neurons responsive to fat
CXCL12促进对脂肪敏感的下丘脑肽神经元的发育
  • 批准号:
    8857108
  • 财政年份:
    2013
  • 资助金额:
    $ 2.1万
  • 项目类别:
CXCL12 promotes development of hypothalamic peptide neurons responsive to fat
CXCL12促进对脂肪敏感的下丘脑肽神经元的发育
  • 批准号:
    8645839
  • 财政年份:
    2013
  • 资助金额:
    $ 2.1万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 2.1万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了